Clinical Study

Survival Prediction Score: A Simple but Age-Dependent Method Predicting Prognosis in Patients Undergoing Palliative Radiotherapy

Table 1

Patient characteristics.

CharacteristicNumber%

Entire cohort579
Age (years)
 <609616.6
 ≥6048383.4
Gender
 Male35661.5
 Female22338.5
Karnofsky performance status1
 90–1007513.0
 70–8016027.6
 ≤6034359.2
Primary tumor site
 Prostate14525.0
 Breast6711.6
 Lung (small cell)315.4
 Lung (nonsmall cell)10518.1
 Colorectal376.4
 Pancreas91.6
 Bladder325.5
 Other15326.4
Number of RT fractions
 1–411419.7
 5–914024.2
 1021036.3
 11–159015.5
 >15254.3
Dose per fraction (Gy)
 <36010.4
 326245.3
 3.1–3.9162.8
 412521.6
 4.1–5264.5
 >59015.5
Selected target types
 Bone metastases31454.2
 Brain metastases6811.7
 Lymph node metastases345.9
Brain metastases1
 No48383.4
 Yes9215.9
Liver metastases1
 No 45979.3
 Yes11620.0
Lung metastases1
 No45177.9
 Yes12421.4
Adrenal gland metastases1
 No 51889.5
 Yes579.8
Bone metastases1
 No19433.5
 Yes38165.8
Systemic cancer treatment1
 No25644.2
 Within 4 weeks before RT11820.4
 Within 3 months before RT6911.9
 Earlier7913.6

RT: Radiotherapy.
Missing information in some cases.